Genmab | GEN - Чистый доход





Чистый доход Изменить Дата
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Almirall EUR 19.58M 7M 2025-12
Amarin USD -1.22M 6.51M 2025-12
Amgen USD 2.38B 556M 2026-06
argenx SE USD 472M 106M 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Bayer EUR 219M 2.54B 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Demant DKK 1.18B 758M 2026-06
Exelixis USD 212.05M 1.58M 2026-06
Fresenius Medical Care EUR 218.38M 100.38M 2026-06
Genmab DKK 303M 250M 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
GN Store Nord DKK -22M 933M 2026-06
GRIFOLS EUR 154M 81M 2026-06
Hikma Pharmaceutical USD 164M 45M 2025-12
Insmed USD -13.24M 150.32M 2026-06
Lakefront Biotherapeutics EUR 2.11M 12.38M 2026-06
Lonza CHF 426M 119M 2025-06
Merck EUR 490M 169M 2026-06
Novartis USD 3.26B 108M 2026-06
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 343M 1.27B 2026-06
UCB EUR 1.08B 608M 2025-12